Home▸Vitamin B12 Deficiency▸Oral vs Intramuscular B12 Replacement Simulator

💊 Oral vs Intramuscular B12 Replacement Simulator

This model assists in deciding between high-dose oral cyanocobalamin and intramuscular injections based on the cause of vitamin B12 deficiency, such as metformin use, proton pump inhibitors, or malabsorption.

Vitamin B12 Deficiency2DModerate60 FPS
Oral vs Intramuscular B12 Replacement Simulator ↗ Open standalone

Finding the Root Cause of B12 Deficiency

Placeholder: different causes need different replacement strategies.

  • ~30%: Metformin users (placeholder low B12 risk)
  • ~10-30%: PPI long-term use (placeholder reduced absorption)
  • IF loss: Pernicious anemia (placeholder autoimmune cause)
  • Direct loss: Ileal resection (placeholder absorption site removed)

Common causes overview

Placeholder: metformin, PPIs, pernicious anemia, and ileal disease each reduce B12 differently.

Scoring Malabsorption Severity

Placeholder: severity score guides route choice.

  • 0-3: Mild severity (placeholder oral usually fine)
  • 4-6: Moderate severity (placeholder oral with monitoring)
  • 7-10: Severe severity (placeholder IM preferred)
  • ~8-12 wk: Reassessment (placeholder recheck levels)

Severity scoring basis

Placeholder: labs, symptoms, and cause combine into a severity score.

High-Dose Oral Cyanocobalamin — Passive Diffusion Route

Placeholder: high doses push enough B12 through passive diffusion.

  • ~1%: Passive diffusion (placeholder of oral dose absorbed)
  • 1000-2000 mcg: Typical dose (placeholder daily oral dose)
  • Yes: IF-independent (placeholder bypasses IF gate)
  • Mild-moderate: Best for (placeholder severity cases)

Oral pathway mechanism

Placeholder: high concentration gradient drives passive gut absorption.

Intramuscular Injection — Direct Reservoir Filling

Placeholder: IM injection bypasses gut entirely and fills the bloodstream.

  • ~100%: Bioavailability (placeholder injected dose)
  • 1mg IM: Typical schedule (placeholder loading then monthly)
  • Severe cases: Best for (placeholder or neuro symptoms)
  • High: Reliability (placeholder independent of gut)

IM pathway mechanism

Placeholder: injection deposits B12 directly into muscle then blood.

Choosing a Maintenance Therapy Route

Placeholder: maintenance route depends on response and cause reversibility.

  • Oral ok: Reversible cause (placeholder e.g. metformin/PPI)
  • IM ok: Irreversible cause (placeholder e.g. pernicious anemia)
  • 3-6 mo: Monitoring interval (placeholder recheck levels)
  • No response: Switch trigger (placeholder escalate to IM)

Maintenance decision summary

Placeholder: match maintenance route to severity trend and cause.

Placeholder: reassess route if levels fail to normalize.
⚙ Under the hood

This model assists in deciding between high-dose oral cyanocobalamin and intramuscular injections based on the cause of vitamin B12 deficiency, such as metformin use, proton pump inhibitors, or malabsorption.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)